Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
02/2012
02/02/2012WO2012014963A1 Condensed ring pyridine compound
02/02/2012WO2012014910A1 P2x4 receptor antagonist
02/02/2012WO2012014848A1 Flavoniod-derived hes-1 promoter inhibitor
02/02/2012WO2012014699A1 Therapeutic agent for neurological diseases
02/02/2012WO2012014012A1 Method for producing tablets that dissolve rapidly in the mouth and that include form i of olanzapine, resulting tablets and use thereof in the treatment of schizophrenia
02/02/2012WO2012013671A1 Processes for the production of 14 - oxygenated morphinan - 6 - ones
02/02/2012WO2012013595A1 Three-phase controlled-release tablet comprising melatonin and process of preparation
02/02/2012WO2012013343A1 Cis-tetrahydrospiro(cyclohexane-1,1'-pyrido[3,4-b]indol)-4-amine derivatives
02/02/2012WO2012013012A1 Benzo-azacyclic hydroxyethylamine compound, preparation method and uses thereof
02/02/2012WO2012012843A1 Modulators of protease activated receptors
02/02/2012WO2011156901A3 Compounds, compositions and methods for treatment of multiple sclerosis
02/02/2012WO2011151076A3 Monoclonal antibodies targeting amyloid beta oligomers
02/02/2012WO2011149354A8 Mirnas involved in the blood brain barrier function
02/02/2012WO2011126322A3 Composition for treating or preventing degenerative cranial nerve diseases, containing black bean extract
02/02/2012WO2011096728A3 Method for proliferating stem cells by activating c-met/hgf signaling and notch signaling
02/02/2012WO2011063773A3 Crystalline and amorphous forms of almorexant hydrochloride and a method of their preparation
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012WO2011005052A8 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029088 Anti-anxiety composition
02/02/2012US20120029081 Solid Pharmaceutical Compositions Containing Pregabalin
02/02/2012US20120029071 Compositions and methods for treating or preventing radiation injury
02/02/2012US20120029066 Use of flavones for treating psychiatric disorders with sensorimotor gating deficits
02/02/2012US20120029049 Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
02/02/2012US20120029048 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012US20120029035 Compositions and methods for extended therapy with aminopyridines
02/02/2012US20120029029 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
02/02/2012US20120029027 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029017 Pectin-containing jelly formulation
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029013 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
02/02/2012US20120029010 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
02/02/2012US20120029007 Morphinan compounds
02/02/2012US20120029006 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine Compounds
02/02/2012US20120029003 Galectin-3 and statin therapy
02/02/2012US20120028995 Novel compounds for medical use as peptidase effectors
02/02/2012US20120028994 Compounds for the reduction of beta-amyloid production
02/02/2012US20120028991 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands
02/02/2012US20120028986 2-heteroaryl-pyrrolo [3,4-c]pyrrole derivatives, and use thereof as scd inhibitors
02/02/2012US20120028985 Combinational therapy for treating autoimmune disease
02/02/2012US20120028982 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
02/02/2012US20120028977 Subunit Selective NMDA Receptor Potentiators For The Treatment Of Neurological Conditions
02/02/2012US20120028975 Substituted triazolopyridines and analogs thereof
02/02/2012US20120028970 Heteroarylthiomethyl pyridine derivative
02/02/2012US20120028968 Novel dibenzofuranyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
02/02/2012US20120028967 Novel diaza-bicyclononyl-pyrimidinyl derivatives and their medical use
02/02/2012US20120028966 Protein kinase inhibitors
02/02/2012US20120028965 Compounds useful as protein kinase inhibitors
02/02/2012US20120028964 Pharmaceutical combination
02/02/2012US20120028961 6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist
02/02/2012US20120028960 Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
02/02/2012US20120028959 Dihydroorotate dehydrogenase inhibitors
02/02/2012US20120028956 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028955 Bicyclic mglur5 positive allosteric modulators and methods of making and using same
02/02/2012US20120028953 Azetidine Derivatives
02/02/2012US20120028951 Pyridazinone compounds
02/02/2012US20120028950 Substituted heterocyclylbenzylpyrazoles and use thereof
02/02/2012US20120028940 Functionally selective azanitrile alpha-2c adrenoreceptor agonists
02/02/2012US20120028939 Substituted naphthyridines and their use as medicaments
02/02/2012US20120028937 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same
02/02/2012US20120028931 Heterocyclic m-glu5 antagonists
02/02/2012US20120028930 Flupirtine salts and polymorphs
02/02/2012US20120028922 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
02/02/2012US20120028920 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
02/02/2012US20120028905 Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A
02/02/2012US20120028904 Methods, systems, and compositions for calpain inhabition
02/02/2012US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027871 Method of treatment based on polymorphisms of the kcnq1 gene
02/02/2012US20120027857 Controlled release pharmaceutical compositions comprising o-desmethyl-venlafaxine
02/02/2012US20120027856 Pharmaceutical product comprising yeast
02/02/2012US20120027851 Method of reducing somnolence in patients treated with tizanidine
02/02/2012US20120027848 Enzyme Delivery Systems and Methods of Preparation and Use
02/02/2012US20120027843 Hb-egf bound protein complex
02/02/2012US20120027823 Methods of treatment using a gastric retained gabapentin dosage
02/02/2012US20120027816 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
02/02/2012US20120027806 Dose selection of adjuvanted synthetic nanocarriers
02/02/2012US20120027781 Neuroprotective and neurorestorative method and compositions
02/02/2012US20120027777 Ljungan virus with improved replication characteristics
02/02/2012US20120027774 Metalloproteinase 9 binding proteins
02/02/2012US20120027758 Use of anti-cd100 antibodies
02/02/2012US20120027755 Prevention and treatment of alzheimer's disease
02/02/2012US20120027742 Methods for treating adult respiratory distress syndrome
02/02/2012US20120027740 Method and means for producing tissues and tissues obtained
02/02/2012US20120027733 Compositions to effect neuronal growth
02/02/2012US20120027726 Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders
02/02/2012US20120027723 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
02/02/2012US20120027718 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012US20120027677 Prion-specific peptoid reagents
02/02/2012US20120024743 Transdermal pharmaceutical preparations
02/02/2012CA2809113A1 P2x4 receptor antagonist
02/02/2012CA2808797A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors
02/02/2012CA2806821A1 Fused ring pyridine compound
02/02/2012CA2806766A1 Therapeutic agent for neurological diseases
02/02/2012CA2806633A1 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine derivatives
02/02/2012CA2805371A1 Therapeutic agent or prophylactic agent for neuropathic pain
02/01/2012EP2412811A1 Dna vaccine for alzheimer's disease
02/01/2012EP2412719A1 Chi-conotoxin peptides
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 1833